Recent news on Fosamax

Don't Buy The Hype: Big Pharma Targets Women For Drugs They Don't Need  -  25 May 2007
AlterNet,For example, Fosamax cuts the risk of hip fracture from 2 percent to 1 percent, but that small benefit may not be worth the 1.5 percent risk of suffering an

Court Opinion Explains Dismissal of Merck's Fosamax Suit  -  May 24, 2007
Seeking Alpha,That would have allowed Apotex to launch its own generic Fosamax sooner-either by forcing the first filer to launch its generic Fosamax earlier or by

Let's Make May the Month to Tame Osteoporosis Hype  -  May 23, 2007
Women's eNews,In addition, for women with a "-1" or a "-2" screening result, there is no evidence of clear benefit from taking a bisphosphonate such as Fosamax and there

FDA Approves New Dosage Strength Of FOSAMAX PLUS D  -  May 14, 2007
Compliance Home,..."This once-weekly medicine now contains both the well-documented fracture benefits of FOSAMAX as well as 5600 IU of vitamin D3.

Fosamax Linked to Heart Problems  -  May 11, 2007
SpiritIndia,Fosamax, a leading osteoporosis drug, has been connected to problems with irregular heart rhythm. Along with Reclast, another bone-building drug,

Fosamax: Update Your Warnings  -  Apr 27, 2007
Lawyers and Settlements,Sacramento, CA: For many post-menopausal women, doctors routinely prescribed hormone replacement therapy (HRT) and Fosamax, a drug that allegedly helps

Apotex Opposes Court Dismissal of Merck's Fosamax Suit  -  Apr 26, 2007
Seeking Alpha,Aaron F. Barkoff submits: A year ago, Merck (MRK) sued Apotex alleging that Apotex's ANDA for generic Fosamax infringed nine patents on pharmaceutical

Weakness might mean more than aging  -  May 22, 2007
Burlington Times News,I am now taking Fosamax once a week. Since stopping the HRT treatment, I’ve gained about 20 pounds, not really a bad thing since I was always underweight.

Generics press for review of Merck patent  -  May 13, 2007
MSNBCGeneric drugmakers have complained to the European Patent Office over the body's surprise restoration of a patent for Merck's blockbuster drug Fosamax.

Building bones ... naturally  -  May 18, 2007
Marin Independent-Journal,According to the New England Journal of Medicine, a three-year study of Fosamax indicated that it stopped fractures in 3 percent of the women taking it.

Consider risk/benefit ratio with medications  -  May 21, 2007
Monterey County Herald,I do agree on the risks of using Fosamax, Actonel and Boniva. Then I found a letter from a pharmacist giving his opinion on Evista. He is correct.

Statement by Merck & Co., Inc., Regarding the Fracture ...  -  May 2, 2007
WebWire (press release),FIT was the largest clinical study ever conducted to evaluate the effect of FOSAMAX® (alendronate sodium) on the risk of osteoporotic fracture.

Studies Tie Drugs, Unusual Heart Rhythms  -  May 2, 2007
WTOP,But there was a hint of similar trouble in a few women who took the leading osteoporosis pill, Fosamax by Merck & Co. The two drugs are in the same class.

Alendronate Once-a-week Formulation Patent Threat Still Alive in ...  -  May 17, 2007
PharmaLive.com (press release),2007 - Following the grant of a divisional patent in Europe which effectively reinstates previously-revoked patent protection of the Fosamax (Alendronic

Studies tie drugs, unusual heart rhythms  -  May 3, 2007
Meadow Free Press,Fosamax, the Merck brand name for alendronate, is now used by an estimated 1.8 million American women. In a letter to the medical journal, Cummings reported

Studies hint at heart rhythm problem with bone-building drugs  -  May 2, 2007
Newsday,But there was a hint of similar trouble in a few women who took the leading osteoporosis pill, Fosamax by Merck & Co., which is based in Whitehouse Station,

New hope, concern on osteoporosis  -  May 3, 2007
Philadelphia Inquirer,Inc.'s blockbuster Fosamax ushered in the current era. About nine osteoporosis drugs, worth $6.2 billion last year, were taken by tens of millions of women

Bone drugs may pose risk  -  May 3, 2007
Sun-Sentinel.com,But there was a hint of similar trouble in a few women who took the leading osteoporosis pill, Fosamax, by Merck & Co. The two drugs are in the same class.

Piribo: New Report on the Women's Health Pharmaceutical Market to 2011  -  May 11, 2007
PR Web (press release),Although Merck held the leading position among competing companies in the WH market in 2005, its marketed franchise comprises of a lone product, Fosamax,

Anti-osteoporosis Drugs Could Result in Irregular Heart Rhythm ...  -  May 3, 2007
MedIndia,Research has revealed some disturbing link between Reclast, made by Novartis AG and Fosamax manufactured by Merck and Co and irregular heart rhythm,

Rare disease hasn't defeated teen's champion spirit  -  May 17, 2007
Checkbiotech.org (press release),The prednisone causes calcium to leak out of my bones, forming these gross bumps in my skin, so I have to take Fosamax in order to counter that.

Regain muscle tone through exercise  -  Apr 30, 2007
Chicago Daily Herald,However, recently, I was doing research on Fosamax and discovered that osteonecrosis of the jaw could be a side effect, albeit a rare one.

Gott: Path to strong muscles - Exercise  -  Apr 30, 2007
Northwest Herald,However, recently, I was doing research on Fosamax and discovered that osteonecrosis of the jaw could is a side effect, albeit a rare one.

Cranberry juice home cure for bladder infection ASKDR.GOTT Peter ...  -  May 4, 2007
Monterey County Herald,Dear Dr. Gott: I am 81 years old and have been taking Fosamax for two years. My recent trip to the periodontist revealed bone damage.

Reclast found to cause abnormal heart rhythms  -  May 3, 2007
News-Medical.net,A similar effect has been seen with Merck's equivalent Fosamax which is the same class of drug but is taken in an oral form.

Drug curbs bone loss after spinal cord injury  -  May 7, 2007
Scientific AmericanNEW YORK (Reuters Health) - The bone drug Fosamax (also called alendronate) given soon after spinal cord injury prevents bone loss associated with the

The Ultimate in Drug Adherence  -  May 16, 2007
HealthandAge.com...class of drugs that slow the destruction of bone that occurs in osteoporosis; the original representative was a daily tablet - alendronate, or Fosamax®.

Once-a-year drug targets osteoporosis  -  May 3, 2007
Los Angeles Times,Although drugs like Fosamax and Actonel are also effective at preventing bone loss and reducing the major health risks associated with fractures,

Once-a-year treatment for bone loss, promising  -  May 3, 2007
Oakland Tribune,...osteoporosis drugs — such as Fosamax, Actonel and Boniva — are typically administered in a weekly or monthly pill or liquid form.

New Treatment Shows Promise in Fighting Bone Loss  -  May 3, 2007
International News Service,Common osteoporosis drugs -- such as Fosamax, Actonel and Boniva - - are typically administered in a weekly or monthly pill or liquid form.

New osteoporosis treatment touted  -  May 3, 2007
Centre Daily Times,Although drugs such as Fosamax and Actonel are effective at preventing bone loss and reducing the major health risks associated with fractures,

Muscle weakness might be more than aging  -  May 15, 2007
Monterey County Herald,I am now taking Fosamax once a week. Since stopping the HRT treatment, I've gained about 20 pounds, not really a bad thing since I was always underweight.

Experimental osteoporosis drug found to curb fractures  -  May 2, 2007
Milwaukee Journal Sentinel (subscription),However, some of the drugs, which include Fosamax, Actonel and Boniva, are hard to take. Each oral dose must be taken with a full glass of water,

Once-a-year bone drug infusion reduces fractures  -  May 2, 2007
San Mateo County Times,...osteoporosis drugs -- such as Fosamax, Actonel and Boniva -- are typically administered in a weekly or monthly pill or liquid form.

Once-a-year bone drug infusion reduces fractures  -  May 2, 2007
Mercury-Register,Common osteoporosis drugs -- such as Fosamax, Actonel and Boniva -- are typically administered in a weekly or monthly pill or liquid form.

Merck & Co. Inc.: A Big Pharma comeback  -  May 14, 2007
Blogging StocksIn 2008, it will lose osteoporosis drug, Fosamax, and glaucoma drug Cosopt, and in 2010, the patent for anti-hypertensive drug, Cozaar.

Apotex Opposes Court Dismissal of Merck's Fosamax Suit  -  26 Apr 2007
Seeking Alpha,Aaron F. Barkoff submits: A year ago, Merck (MRK) sued Apotex alleging that Apotex's ANDA for generic Fosamax infringed nine patents on pharmaceutical

Focus on the Women's Health Market to 2011  -  26 Apr 2007
PharmaLive.com (press release),Although Merck held the leading position among competing companies in the WH market in 2005, its marketed franchise comprises of a lone product, Fosamax,

Consumer Outreach Boosts Generic Cholesterol-Fighting Drugs  -  26 Apr 2007
PharmaLive.com (press release),Looking ahead, plan sponsors can use it to take advantage of generics coming on the market for Ambien(R), Imitrex(R) and Fosamax(R)," said Cox.

Local pharmaceutical firm plans to go public  -  Apr 24, 2007
Wilmington Morning Star,Merrion's most advanced product is a tweak to the active ingredient in Fosamax, a leader in the multibillion-dollar world of osteoporosis treatments.

A Boost for Aging Bones  -  Apr 22, 2007
Better Homes and GardensQ. For post-menopausal women (I am 67), is it necessary to take either Fosamax or hormones for bone health? What are the side effects?

Fosamax Contributed to Jaw Bone Loss  -  Apr 4, 2007
Lawyers and Settlements,Wolcott, NY: "I was on Fosamax for three years until x-rays found decalcification in my jaw," says Fay Sedore. "I thought this medication was supposed to

Prostate cancer patients should use Fosamax  -  Apr 4, 2007
TopCancerNews.com,The Annals of Internal Medicine published an article that says Fosamax (alendronate) can prevent and even reverse bone loss associated with hormonal

Weekly Oral Fosamax® Prevents Bone Loss in Patients with Prostate ...  -  Mar 29, 2007
Cancer Consultants (press release),According to an article recently published in the Annals of Internal Medicine, the bisphosphate Fosamax® (alendronate) can prevent and reverse bone loss

Merck marks Fosamax patent victory  -  Mar 28, 2007
MSNBCThe reinstatement by the European Patent Office of the patent for the once-weekly Fosamax treatment, the most popular dosing form, could trigger lawsuits by

Weekly Oral Fosamax® Prevents Bone Loss in Patients with Prostate ...  -  Mar 28, 2007
Cancer Consultants (press release),Researchers from the University of Pittsburgh, Pennsylvania and Roswell Park Institute have reported the weekly oral Fosamax (alendronate) can prevent and

Merck & Co wins EU patent reinstatement on osteoporosis ...  -  Mar 28, 2007
Forbes,LONDON (AFX) - Merck & Co Inc said it has obtained a new European patent for its osteoporosis drug Fosamax, which had sales of more than 3 bln usd last year

How to prevent osteoporosis  -  Apr 20, 2007
iAfrica.com,Some people are now recommending that between five and ten years of HRT followed by treatment with the new bisphosphonates such as Fosamax® is the right

Merck Reports Strong Financial Results for First-Quarter 2007  -  Apr 19, 2007
PharmaLive.com (press release),Global sales for FOSAMAX and FOSAMAX PLUS D (marketed as FOSAVANCE throughout the European Union) were $742 million for the first quarter, representing a

Merck's Q1 profit rises  -  Apr 20, 2007
Pharma Times (subscription),Revenues from Fosamax (alendronate) and Fosamax Plus D were less solid, faling by 2% from the previous year to $742 million.

Merck 1Q Profit Jumps 12 Percent  -  Apr 19, 2007
The Times and Democrat,The Whitehouse Station, NJ-based maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted net income of $1.7 billion, or 78 cents per

FDA Ruling Gives Actonel Boost In Osteoporosis-Drug War  -  Apr 17, 2007
AdAge.com (subscription)...s Fosamax and P&G's Actonel have up to now had to be taken weekly. While it may not seem like a huge advantage, it's been the basis of a $100 million ad

READINGTON: Merck & Co. net rises 12 percent  -  Apr 19, 2007
Bridgewater Courier News,The Readington-based maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted net income of $1.7 billion, or 78 cents per share,

Higher sales boost Merck's profits  -  Apr 19, 2007
Asbury Park Press,The maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted net income of $1.7 billion, or 78 cents per share, up from $1.52 billion

Plan D prices soar  -  Apr 20, 2007
Asbury Park Press,The increase is even higher for seniors taking Fosamax, an osteoporosis treatment that is up 10.7 percent; Prevacid, a gastrointestinal agent up 10.9

Dow inches higher to record close  -  Apr 20, 2007
New York Daily News,Merck said its net income jumped 12% to $7.1 billion, main-ly due to sharply higher sales of its asthma drug Singulair and Fosamax for osteoporosis.

Merck finds tonic in clever turn of phrase  -  Mar 29, 2007
MSNBCIt took just a few words to allow Merck to seize control again of the patent on its once-weekly dose of Fosamax, a blockbuster osteoporosis drug.

Drugmaker Merck sees profits jump 12%  -  Apr 19, 2007
Toronto Star,The maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted net income of $1.7 billion (figures US), or 78 cents per share,

Merck first-quarter net jumps 12% on higher sales  -  Apr 19, 2007
USA TodayThe maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted net income of $1.7 billion, or 78 cents a share, up from $1.52 billion,

Merck first-quarter net jumps 12 percent on higher sales  -  Apr 19, 2007
International Herald Tribune,The maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted net income of $1.7 billion (€1.25 billion), or 78 cents per share,

Higher sales push Merck profit higher  -  Apr 19, 2007
Globe and Mail,The maker of Fosamax for osteoporosis and Singulair for asthma and allergies posted profit of $1.7-billion (US), or 78 cents per share,

Merck 1Q profit jumps 12 percent  -  Apr 19, 2007
Jordan Falls News,Sales of Singulair jumped 25 percent to $1 billion, while Fosamax sales dipped 2 percent to $742 million. Companion blood pressure drugs Cozaar and Hyzaar

Merck, Schering-Plough bolstered by sales  -  Apr 19, 2007
Crain's New York Business,The Whitehouse Station, NJ-based maker of Fosamax for osteoporosis and Singulair for asthma and allergies earned $1.7 billion, or 78 cents per share,

Merck Does OK  -  Apr 19, 2007
24/7 Wall St.,Global sales for FOSAMAX were flat at $742 million. For a company near its 52-week high, it was not a break-out quarter. The company's shares are up over

Side effect of jaw osteonecrosis  -  Apr 16, 2007
Sarasota Herald-Tribune,Dear Dr. Donohue: After a bone density test, my physician prescribed Fosamax. I have heard that it has a serious side effect -- jaw decay.

April 2007 Big Pharma Litigation Update - Drugs Part I  -  Apr 5, 2007
Lawyers and Settlements,A large number of lawsuits have also been filed against Merck, over the osteoporosis drug Fosamax, and against Johnson and Johnson, over the Ortho-Evra

Jaw problems a rare complication of osteoporosis drug  -  Apr 15, 2007
Chattanooganow (subscription),DONOHUE: After a bone density test, my physician prescribed Fosamax. I have heard that it has a serious side effect -- jaw decay. Would you take it? -- HM

Osteoporosis drugs rarely cause trouble in jawbone  -  Apr 15, 2007
SouthCoastToday.com,DONOHUE: After a bone density test, my physician prescribed Fosamax. I have heard that it has a serious side effect — jaw decay. Would you take it?

European generics suppliers hit  -  Apr 2, 2007
Chemistry World,The patent covering the once-weekly dose of the $3 billion (£1.5 billion)-a-year drug now reads that alendronate (Fosamax) is used to treat osteoporosis.

Another Successful Levin Papantonio and Mass Torts Made Perfect ...  -  Apr 2, 2007
PharmaLive.com (press release),Accutane, Fosamax, Ketek, Ortho Evra, ReNu with MoistureLoc, Trasylol and Vioxx and Tobacco litigation are among a few of the cases the Levin Papantonio law

Study Finds TV Pharma Ads Less Effective Than Print  -  Apr 11, 2007
MediaPost Publications,For example, 43% of people who suffer with osteoporosis recalled a TV ad for Fosamax Plus D compared with only 19% of non-sufferers.

OTC painkillers fine for Paget’s symptoms Ask Dr. H Mitchell Hecht  -  Apr 10, 2007
Wilkes Barre Times-Leader,If there’s an elevated calcium level or osteoporosis from excessive bone turnover, drugs like calcitonin, Fosamax, Actonel and Forteo are used.

Merck blockbusters lift revenue prospects  -  Apr 4, 2007
NorthJersey.com,Notwithstanding the introduction of a generic version of its blockbuster osteoporosis drug Fosamax in 2008, Merck's future is bright.

Midday Leaders & Laggards: DJIA  -  Mar 29, 2007
Forbes,...biggest midday gain on the Dow Jones industrial average Thursday after the European Patent Office restored Merck's patent on osteoporosis drug Fosamax.

Pipeline Insight: Osteoporosis - Intermittent dosing drives market ...  -  Mar 30, 2007
Pharmaceutical Business ReviewDespite the genericization of the market leader Fosamax and patent expiries on other key brands, pipeline products are still viable.

Merck Forced To Put Unsuccessful Insomnia Drug To Sleep  -  Mar 29, 2007
Seeking Alpha,In other news yesterday, Merck was granted an unusual reinstatement of a critical European patent for its third-biggest drug Fosamax, an osteoporosis

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional